(-)-demecolcine decreases expression ISO RGD:731648 6480464 Demecolcine results in decreased expression of SIX1 mRNA CTD PMID:23649840 1,2-dichloroethane increases expression ISO RGD:1550080 6480464 ethylene dichloride results in increased expression of SIX1 mRNA CTD PMID:28960355 15-acetyldeoxynivalenol increases expression ISO RGD:731648 6480464 15-acetyldeoxynivalenol results in increased expression of SIX1 mRNA CTD PMID:23792671 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550080 6480464 Tetrachlorodibenzodioxin affects the expression of SIX1 mRNA CTD PMID:16962184 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SIX1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550080 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SIX1 promoter] CTD PMID:19654925 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SIX1 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731648 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SIX1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1550080 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SIX1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1550080 6480464 Fenretinide results in decreased expression of SIX1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SIX1 mRNA CTD PMID:22504374 , PMID:24780913 aflatoxin B1 increases expression ISO RGD:731648 6480464 Aflatoxin B1 results in increased expression of SIX1 mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:731648 6480464 Aflatoxin B1 results in decreased methylation of SIX1 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:731648 6480464 Tretinoin results in increased expression of SIX1 mRNA CTD PMID:21934132 amiodarone increases expression ISO RGD:731648 6480464 Amiodarone results in increased expression of SIX1 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SIX1 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:731648 6480464 Antimycin A results in decreased expression of SIX1 mRNA CTD PMID:33512557 antirheumatic drug increases expression ISO RGD:731648 6480464 Antirheumatic Agents results in increased expression of SIX1 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:731648 6480464 arsenite promotes the reaction [G3BP1 protein binds to SIX1 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO RGD:1550080 6480464 Benzo(a)pyrene results in decreased expression of SIX1 mRNA CTD PMID:22228805 , PMID:22610609 benzo[a]pyrene increases expression ISO RGD:731648 6480464 Benzo(a)pyrene results in increased expression of SIX1 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:731648 6480464 Benzo(a)pyrene results in decreased methylation of SIX1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:731648 6480464 Benzo(a)pyrene results in increased methylation of SIX1 3' UTR CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO RGD:1550080 6480464 benzo(b)fluoranthene results in decreased expression of SIX1 mRNA CTD PMID:26377693 bisphenol A affects methylation ISO RGD:1550080 6480464 bisphenol A affects the methylation of SIX1 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SIX1 mRNA CTD PMID:33296240 bisphenol A increases expression ISO RGD:1550080 6480464 bisphenol A results in increased expression of SIX1 mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SIX1 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol F increases expression ISO RGD:731648 6480464 bisphenol F results in increased expression of SIX1 mRNA CTD PMID:33476716 bisphenol F increases expression ISO RGD:1550080 6480464 bisphenol F results in increased expression of SIX1 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:731648 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SIX1 mRNA CTD PMID:28628672 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SIX1 mRNA CTD PMID:19167457 carbamazepine affects expression ISO RGD:731648 6480464 Carbamazepine affects the expression of SIX1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1550080 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone decreases expression ISO RGD:1550080 6480464 Chlordecone results in decreased expression of SIX1 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1550080 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX1 gene CTD PMID:20938992 copper atom multiple interactions ISO RGD:731648 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SIX1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:731648 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SIX1 mRNA CTD PMID:20971185 dexamethasone multiple interactions ISO RGD:731648 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SIX1 mRNA CTD PMID:28628672 diallyl trisulfide decreases expression ISO RGD:731648 6480464 diallyl trisulfide results in decreased expression of SIX1 mRNA CTD PMID:34995734 dibenz[a,h]anthracene decreases expression ISO RGD:1550080 6480464 1 more ... CTD PMID:26377693 diethylstilbestrol increases expression ISO RGD:1550080 6480464 Diethylstilbestrol results in increased expression of SIX1 mRNA CTD PMID:17394237 , PMID:27259717 diethylstilbestrol decreases expression ISO RGD:1550080 6480464 Diethylstilbestrol results in decreased expression of SIX1 mRNA CTD PMID:15171707 dioxygen increases expression ISO RGD:731648 6480464 Oxygen deficiency results in increased expression of SIX1 mRNA CTD PMID:24236059 dorsomorphin multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 folic acid multiple interactions ISO RGD:1550080 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX1 gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1550080 6480464 fulvestrant inhibits the reaction [Genistein results in decreased expression of SIX1 mRNA] CTD PMID:21810550 genistein multiple interactions ISO RGD:1550080 6480464 fulvestrant inhibits the reaction [Genistein results in decreased expression of SIX1 mRNA] CTD PMID:21810550 genistein increases expression ISO RGD:1550080 6480464 Genistein results in increased expression of SIX1 mRNA, Genistein results in increased expression of SIX1 protein CTD PMID:21810550 more ... gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SIX1 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:731648 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SIX1 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1550080 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX1 gene CTD PMID:20938992 lithium chloride increases expression ISO RGD:731648 6480464 Lithium Chloride results in increased expression of SIX1 mRNA, Lithium Chloride results in increased expression of SIX1 protein CTD PMID:19101580 lithium chloride increases response to substance ISO RGD:731648 6480464 SIX1 protein results in increased susceptibility to Lithium Chloride CTD PMID:19101580 mercury dibromide increases expression ISO RGD:731648 6480464 mercuric bromide results in increased expression of SIX1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SIX1 mRNA CTD PMID:22504374 methylmercury chloride increases expression ISO RGD:731648 6480464 methylmercuric chloride results in increased expression of SIX1 mRNA CTD PMID:28001369 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SIX1 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:731648 6480464 p-Chloromercuribenzoic Acid results in increased expression of SIX1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:731648 6480464 panobinostat results in increased expression of SIX1 mRNA CTD PMID:26272509 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SIX1 mRNA CTD PMID:33387578 phenylmercury acetate increases expression ISO RGD:731648 6480464 Phenylmercuric Acetate results in increased expression of SIX1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1550080 6480464 pirinixic acid results in increased expression of SIX1 mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO RGD:731648 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SIX1 mRNA CTD PMID:19710929 rotenone decreases expression ISO RGD:731648 6480464 Rotenone results in decreased expression of SIX1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite affects methylation ISO RGD:731648 6480464 sodium arsenite affects the methylation of SIX1 gene CTD PMID:28589171 temozolomide increases expression ISO RGD:731648 6480464 Temozolomide results in increased expression of SIX1 mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1550080 6480464 Testosterone results in decreased expression of SIX1 mRNA CTD PMID:19693291 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SIX1 mRNA CTD PMID:33387578 titanium dioxide affects expression ISO RGD:1550080 6480464 titanium dioxide affects the expression of SIX1 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:1550080 6480464 titanium dioxide results in decreased expression of SIX1 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SIX1 mRNA CTD PMID:25729387 triazines multiple interactions ISO RGD:1550080 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of SIX1 mRNA] CTD PMID:27469509 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SIX1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:731648 6480464 trichostatin A results in increased expression of SIX1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 troglitazone decreases expression ISO RGD:1550080 6480464 troglitazone results in decreased expression of SIX1 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO RGD:1550080 6480464 trovafloxacin results in increased expression of SIX1 mRNA CTD PMID:35537566 urethane increases expression ISO RGD:731648 6480464 Urethane results in increased expression of SIX1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:731648 6480464 Valproic Acid results in decreased methylation of SIX1 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:731648 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIX1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731648 6480464 Valproic Acid results in increased expression of SIX1 mRNA, Valproic Acid results in increased expression of SIX1 protein CTD PMID:19101580 more ... valproic acid increases expression ISO RGD:1550080 6480464 Valproic Acid results in increased expression of SIX1 mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:731648 6480464 Valproic Acid affects the expression of SIX1 mRNA CTD PMID:25979313 valproic acid increases response to substance ISO RGD:731648 6480464 SIX1 protein results in increased susceptibility to Valproic Acid CTD PMID:19101580 vanadyl sulfate decreases expression ISO RGD:731648 6480464 vanadyl sulfate results in decreased expression of SIX1 mRNA CTD PMID:16330358 vincristine decreases expression ISO RGD:731648 6480464 Vincristine results in decreased expression of SIX1 mRNA CTD PMID:23649840